Makoto Kawashima - Search Results

Year	Number of Results
2000	2
2001	1
2002	9
2003	5
2004	9
2005	8
2006	3
2007	2
2008	5
2009	4
2010	8
2011	11
2012	10
2013	12
2014	15
2015	8
2016	15
2017	13
2018	9
2019	5
2020	6
2021	5
2022	7
2023	8
2024	2

1

Efficacy and safety of intravenous fosphenytoin for patients with acute herpes zoster-associated pain: A placebo-controlled randomized trial.

Iseki M, Yamamoto T, Ogawa Y, Majima Y, Abe Y, Watanabe D, Amaya F, Hasegawa T, Inafuku K, Kosugi T, Nomura Y, Deguchi T, Hamada T, Shimizu K, Arai S, Takahashi M, Hamada I, Ishikawa Y, Kawashima M. Iseki M, et al. Among authors: kawashima m. J Dermatol. 2024 Feb;51(2):234-242. doi: 10.1111/1346-8138.17054. Epub 2023 Dec 27. J Dermatol. 2024. PMID: 38149403 Clinical Trial.

2

Safety and tolerability of onabotulinumtoxinA in the treatment of upper facial lines from global registration studies in 5298 participants: A meta-analysis.

Brin MF, De Boulle K, Liew S, Carruthers A, Carruthers J, Rivkin A, Wu Y, Kawashima M, Yushmanova I, Boodhoo TI, Lee E. Brin MF, et al. Among authors: kawashima m. JAAD Int. 2023 Sep 9;14:4-18. doi: 10.1016/j.jdin.2023.07.021. eCollection 2024 Mar. JAAD Int. 2023. PMID: 38035126 Free PMC article.

3

The effectiveness of S-LEC™ solar control film L in laminated glass for reducing the burning sensation caused by near-infrared radiation.

Shinohara K, Nomachi A, Kawashima M. Shinohara K, et al. Among authors: kawashima m. J Cosmet Dermatol. 2023 Dec;22(12):3500-3504. doi: 10.1111/jocd.15876. Epub 2023 Sep 4. J Cosmet Dermatol. 2023. PMID: 37667543

4

Near-infrared radiation causes sebaceous gland enlargement along with an ROS-dependent augmentation of epidermal growth factor receptor expression in hamsters.

Tanaka S, Sakaue H, Koiwai T, Okuda N, Okuyama K, Horioka Y, Hiramatsu Y, Kawashima M, Ishiguro N, Sato T. Tanaka S, et al. Among authors: kawashima m. Exp Dermatol. 2023 Oct;32(10):1717-1724. doi: 10.1111/exd.14878. Epub 2023 Jul 4. Exp Dermatol. 2023. PMID: 37401827

5

Nemolizumab Improves Patient-Reported Symptoms of Atopic Dermatitis with Pruritus: Post Hoc Analysis of a Japanese Phase III Randomized Controlled Trial.

Kabashima K, Matsumura T, Komazaki H, Kawashima M; Nemolizumab-JP01 Study Group. Kabashima K, et al. Among authors: kawashima m. Dermatol Ther (Heidelb). 2023 Apr;13(4):997-1011. doi: 10.1007/s13555-023-00901-7. Epub 2023 Mar 11. Dermatol Ther (Heidelb). 2023. PMID: 36905481 Free PMC article.

6

Clinically meaningful improvements in cutaneous lesions and quality of life measures in patients with atopic dermatitis with greater pruritus reductions after treatment with 60 mg nemolizumab subcutaneously every 4 weeks: subgroup analysis from a phase 3, randomized, controlled trial.

Kabashima K, Matsumura T, Hayakawa Y, Kawashima M; Nemolizumab-JP01 Study Group. Kabashima K, et al. Among authors: kawashima m. J Dermatolog Treat. 2023 Dec;34(1):2177096. doi: 10.1080/09546634.2023.2177096. J Dermatolog Treat. 2023. PMID: 36779675 Free article. Clinical Trial.

7

Electroretinographic Assessments of Macular Function after Brilliant Blue G Staining for Inner Limiting Membrane Peeling.

Terauchi G, Shinoda K, Yagura K, Kawashima M, Matsumoto SC, Mizota A, Miyake Y. Terauchi G, et al. Among authors: kawashima m. J Clin Med. 2022 Oct 29;11(21):6404. doi: 10.3390/jcm11216404. J Clin Med. 2022. PMID: 36362633 Free PMC article.

8

A phase 3, randomized, double-blind, placebo-controlled study evaluating a single, patient-initiated dose of amenamevir for recurrent herpes labialis.

Kawashima M, Watanabe D, Fujio K, Komazaki H. Kawashima M, et al. J Dermatol. 2023 Mar;50(3):311-318. doi: 10.1111/1346-8138.16608. Epub 2022 Nov 9. J Dermatol. 2023. PMID: 36353762 Clinical Trial.

9

Adhesion of Asian Dust Particles to Verofilcon a Soft Contact Lenses.

Mimura T, Fujishima H, Uchio E, Fukagawa K, Inoue Y, Kawashima M, Kitsu K, Mizota A. Mimura T, et al. Among authors: kawashima m. Clin Optom (Auckl). 2022 Oct 28;14:215-221. doi: 10.2147/OPTO.S381763. eCollection 2022. Clin Optom (Auckl). 2022. PMID: 36329953 Free PMC article.

10

Single-Dose, Patient-Initiated Amenamevir Therapy for Recurrent Genital Herpes: A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study.

Kawashima M, Imafuku S, Fujio K, Komazaki H. Kawashima M, et al. Open Forum Infect Dis. 2022 Sep 22;9(10):ofac494. doi: 10.1093/ofid/ofac494. eCollection 2022 Oct. Open Forum Infect Dis. 2022. PMID: 36267254 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

146 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

146 results

Results by year